Aug 04, 2021 07:48 PM (GMT+8) · EqualOcean
Today, relx Yueke (fog core technology RLX. US), an e-cigarette enterprise listed in the United States, announced that its declared e-cigarette clinical trial has been successfully registered in China Clinical Trial Registration Center (ChiCTR) and who international clinical trial registration platform (who ICTRP). This is the first electronic cigarette clinical research project in China that has passed ethical review and expert review and has been approved for implementation, filling the gap in domestic electronic cigarette clinical research. It is reported that the three-month project will study the metabolic kinetics of nicotine in subjects and the impact on human biomarkers after replacing cigarettes with Yueke products. At present, the research team has basically completed the methodological verification of biomarkers in human body.
Related companies: